MET and cancer: In the majority of cancers, including HNSCC, MET is transcriptionally activated by stimuli such as hypoxia, inflammatory cytokines, stromal HGF, and pro-angiogenic factors, often abundantly present in the reactive tumor-associated stroma [7,13,18,19].